Bioprocessing

UC Davis and Startup Scale Up Lab-Grown Chocolate Production
Biotech & Bioprocessing UC Davis and Startup Scale Up Lab-Grown Chocolate Production

Global chocolate consumption continues to surge toward a projected market value of nearly thirty-eight billion dollars by 2029, even as traditional cacao farming faces an existential threat from climate instability and ethical controversies. This widening gap between demand and sustainable supply

Can Lab-Grown Cells Trigger Lasting Cancer Immunity?
Research & Development Can Lab-Grown Cells Trigger Lasting Cancer Immunity?

The sophisticated machinery of the human immune system often encounters a catastrophic breakdown when faced with aggressive malignancies that systematically dismantle the body's natural defense networks. While the immune system is theoretically designed to identify and destroy internal threats,

T Cell-Derived Extracellular Vesicles – Review
Tech & Innovation T Cell-Derived Extracellular Vesicles – Review

The discovery that activated T cells deploy specialized genetic messengers represents one of the most transformative shifts in our understanding of how the human immune system orchestrates its counter-offensives against aggressive malignancies. This breakthrough centers on extracellular vesicles

How Can Stem Cell Memory Improve CAR T-Cell Therapy?
Research & Development How Can Stem Cell Memory Improve CAR T-Cell Therapy?

The clinical landscape of oncology shifted dramatically with the birth of cellular engineering, yet the early excitement often masked a persistent struggle against the rapid exhaustion of the very tools designed to save lives. While Chimeric Antigen Receptor (CAR) T-cell therapy has achieved

How Will VALANX’s New Board Advance Cancer Drug Development?
Research & Development How Will VALANX’s New Board Advance Cancer Drug Development?

The precision required to dismantle a tumor without devastating the surrounding healthy tissue remains one of the most elusive targets in modern oncology. While the pharmaceutical industry has long sought to perfect antibody-drug conjugates (ADCs), the technical reality often falls short of the

Can Tozorakimab Redefine Treatment for Chronic COPD?
Biotech & Bioprocessing Can Tozorakimab Redefine Treatment for Chronic COPD?

Chronic obstructive pulmonary disease has long remained a primary cause of global mortality, yet the therapeutic options available to millions of suffering patients have seen little fundamental change for decades. This persistent challenge took a major turn on March 27, 2026, when AstraZeneca

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later